{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:49:52Z","timestamp":1777639792056,"version":"3.51.4"},"reference-count":45,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Low-dose acetylsalicylic acid (ASA) is widely used during pregnancy to prevent obstetric complications of placental dysfunction, such as preeclampsia, stillbirth and fetal growth restriction, and obstetric complications in pregnant women with antiphospholipid syndrome. ASA-sensitive pregnant women cannot benefit from the effects of ASA due to the possibility of severe or potentially life-threatening hypersensitivity reactions to ASA. ASA desensitization is a valuable and safe therapeutic option for these women, allowing them to start daily prophylaxis with ASA and prevent pregnancy complications. The authors discuss the recent advances in obstetric conditions preventable by ASA and the management of ASA hypersensitivity in pregnancy, including ASA desensitization. To encourage the implementation of ASA desensitization protocols in ASA-sensitive pregnant women, they also propose a practical approach for use in daily clinical practice.<\/jats:p>","DOI":"10.3390\/medicina57040390","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T22:15:13Z","timestamp":1618784113000},"page":"390","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women"],"prefix":"10.3390","volume":"57","author":[{"given":"Filipe","family":"Benito-Garcia","sequence":"first","affiliation":[{"name":"Immunoallergy Department, CUF Descobertas Hospital, 1998-018 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-5323","authenticated-orcid":false,"given":"In\u00eas","family":"Pires","sequence":"additional","affiliation":[{"name":"S\u00e3o Bernardo Hospital, Centro Hospitalar de Set\u00fabal, 2910-549 Set\u00fabal, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0831-2741","authenticated-orcid":false,"given":"Jorge","family":"Lima","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, CUF Descobertas Hospital, 1998-018 Lisbon, Portugal"},{"name":"Comprehensive Health Research Centre (CHRC), CEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists (2018). ACOG committee opinion no. 743: Low-dose aspirin use during pregnancy. Obstet. Gynecol., 132, e44\u2013e52.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1398-9995.1980.tb01730.x","article-title":"Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review","volume":"35","author":"Settipane","year":"1980","journal-title":"Allergy"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","article-title":"Self-reported drug allergy in a general adult Portuguese population","volume":"34","author":"Gomes","year":"2004","journal-title":"Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)\u2014classification, diagnosis and management: Review of the EAACI\/ENDA(#) and GA2LEN\/HANNA","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0897.2005.00322.x","article-title":"Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients","volume":"55","year":"2006","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.aller.2012.07.013","article-title":"Desensitisation to aspirin in antiphospholipid antibody syndrome","volume":"41","author":"Cernadas","year":"2013","journal-title":"Allergol. Et Immunopathol."},{"key":"ref_8","first-page":"256","article-title":"Aspirin desensitization in a woman with inherited thrombophilia and recurrent miscarriage","volume":"44","author":"Santos","year":"2012","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy (1988). Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am. J. Obstet. Gynecol., 158, 80\u201383.","DOI":"10.1016\/0002-9378(88)90782-X"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Powrie, R., Greene, M., and Camann, W. (2010). Hypertension in pregnancy. de Swiet\u2019s Medical Disorders in Obstetric Practice, Blackwell Publishing.","DOI":"10.1002\/9781444323016"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14390\/jsshp.HRP2019-010","article-title":"New definition and classification of \u201cHypertensive Disorders of Pregnancy (HDP)","volume":"7","author":"Makino","year":"2019","journal-title":"Hypertens. Res. Pregnancy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cll.2016.01.013","article-title":"Aspirin for the prevention of preeclampsia and intrauterine growth restriction","volume":"36","author":"Roberge","year":"2016","journal-title":"Clin. Lab. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(79)91996-2","article-title":"Effect of aspirin on incidence of pre-eclampsia","volume":"1","author":"Crandon","year":"1979","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: Systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: An individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_21","first-page":"41","article-title":"Antiphospholipid syndrome during pregnancy: The state of the art","volume":"5","author":"Valenti","year":"2011","journal-title":"J. Prenat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-015-1309-0","article-title":"Guidance for the treatment and prevention of obstetric-associated venous thromboembolism","volume":"41","author":"Bates","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaip.2016.10.021","article-title":"Current knowledge and management of hypersensitivity to aspirin and NSAIDs","volume":"5","author":"Laidlaw","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mai.2001.116290","article-title":"Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma","volume":"108","author":"Stevenson","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaip.2014.03.014","article-title":"Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis","volume":"2","author":"Aun","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5414\/CPP47596","article-title":"Prevalence of fatal adverse drug reactions in hospitalized patients","volume":"47","author":"Cabello","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease--new prime suspects","volume":"374","author":"Laidlaw","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archderm.139.12.1577","article-title":"Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs","volume":"139","author":"Zembowicz","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1067\/mai.2000.104571","article-title":"Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema","volume":"105","author":"Wong","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2006.06.019","article-title":"Selection of patients for aspirin desensitization treatment","volume":"118","author":"Stevenson","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/dth.12171","article-title":"Aspirin desensitization as a treatment for aspirin-sensitive chronic spontaneous urticaria","volume":"28","author":"Lee","year":"2015","journal-title":"Dermatol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity\u2014A consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2500\/108854193778774065","article-title":"Anaphylaxie et idiosyncrasie","volume":"14","author":"Widal","year":"1993","journal-title":"Allergy Proc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(84)90361-0","article-title":"Aspirin-sensitive rhinosinusitis asthma: A double-blind crossover study of treatment with aspirin","volume":"73","author":"Stevenson","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.reval.2010.11.002","article-title":"Protocole d\u2019induction de tol\u00e9rance pour l\u2019hypersensibilit\u00e9 \u00e0 l\u2019aspirine","volume":"51","author":"Ozyigit","year":"2011","journal-title":"Rev. Fr. Allergol"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.116.004368","article-title":"Aspirin desensitization in patients with coronary artery disease: Results of the multicenter adapted registry (aspirin desensitization in patients with coronary artery disease)","volume":"10","author":"Rossini","year":"2017","journal-title":"Circulation. Cardiovasc. Interv."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1081-1206(10)62099-6","article-title":"Sensitivity to nonsteroidal anti-inflammatory drugs","volume":"89","author":"Namazy","year":"2002","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1001\/jama.292.24.3017","article-title":"Aspirin sensitivity: Implications for patients with coronary artery disease","volume":"292","author":"Gollapudi","year":"2004","journal-title":"JAMA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.iac.2004.03.008","article-title":"Drug desensitization","volume":"24","author":"Solensky","year":"2004","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ACI.0b013e3280108716","article-title":"Desensitization for drug allergy","volume":"6","author":"Castells","year":"2006","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJM198505093121905","article-title":"Penicillin allergy and desensitization in serious infections during pregnancy","volume":"312","author":"Wendel","year":"1985","journal-title":"N. Engl. J. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/4\/390\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:49:11Z","timestamp":1760161751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/4\/390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,17]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["medicina57040390"],"URL":"https:\/\/doi.org\/10.3390\/medicina57040390","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,17]]}}}